Pharma Pulse 1/15/25: Telemedicine Considerations When Conducting DCTs, Fighting the Flu from Behind the Counter & more

Telemedicine Considerations When Conducting Decentralized Clinical Trials

Compliance with state telemedicine requirements is imperative, as not only will most clinical trial sponsors contractually require such compliance, but non-compliance may also subject the practitioner to licensure violations and liability.

Fighting Influenza from Behind the Counter: A Treatment Review

Pharmacists should prioritize the needs of the patient in front of them and determine what matters most in each specific situation.

Moderna 2025 Revenue Guidance Below Wall Street’s Estimates

The biotech plans to deliver up to 10 product approvals over the next three years, while reducing costs across the business.

DarioHealth Expands GLP-1 Weight-Loss Solution, Unlocking New Revenue Streams in Rapidly Growing Multi Billion Dollar Market

Market News Alerts Updates that DarioHealth Corp. is taking another bold step into the rapidly growing weight-loss market, now projected to exceed $100 billion annually by 2030. The company’s latest move expands its GLP-1 offering with prescribing capabilities, positioning Dario to capture a larger share of this lucrative space as demand for medical weight-loss solutions skyrockets across employers and consumers.

Carmody Quality Solutions on LinkedIn

The Transformative Potential of #AI in the #Pharmaceutical Industry: Opportunities and Cautions -- via Pharmaceutical Executive

https://lnkd.in/e7n2DwMZ

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs